The nation of Zimbabwe has declined a substantial US healthcare agreement worth 367 million US dollars (272 million pounds) over five years because of the United States' insistence on sensitive data.
This move became public following a internal memorandum from December was disclosed, revealing that Head of State Emmerson Mnangagwa deemed the arrangement was "skewed".
A government representative has since explained that the United States was seeking biological samples for scientific study and commercial gain while was not willing to guarantee the benefits from any future medical innovations.
"We will now turn to the challenging and unfortunate process of winding down our health aid in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy indicated the United States had provided over $1.9bn as health assistance to Zimbabwe during the past two decades.
A doctors' association in Zimbabwe has urged more dialogue to find a deal agreeable to all parties so the country's vital HIV treatment initiative can be sustained.
Wider Context
This development follows a comparable situation in Kenya, where a high court blocked a related deal with the US after legal challenges were raised about the security of citizens' health data.
After returning to office recently, US President Donald Trump has slashed overseas assistance and shut down the US Agency for International Development (USAID).
USAID had managed assistance for the US government, but Trump argued its spending was "inefficient" and his administration was seeking direct bilateral deals to enhance transparency and accountability.
Based on statements, 16 nations in Africa have so far agreed to these new agreements, representing over $18.3bn in committed funds.
Details of the Declined Agreement
This assistance for Zimbabwe was intended to funded "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"We are confident this collaboration would have delivered significant advantages for Zimbabwean communities, particularly the 1.2 million men, women and children currently on HIV treatment through US-supported initiatives," Tremont commented.
However, official spokesman Nick Mangwana said the proposed deal was "unequal".
"Our nation was requested to surrender its biological resources and data over an extended period, without any corresponding guarantee of access to any medical innovations – like new medicines or tests – that could result from that provided information," he stated.
"Put simply, our nation would provide the basic resources for medical research with no certainty that the resulting innovations would be available to our people if a future disease outbreak emerge."
National Interest and International Frameworks
He also pointed out that the American exit from the World Health Organization (WHO) and its push of one-on-one health agreements were upending systems previously established through the global health agency.
Mangwana cited its Pathogen Access and Benefit Sharing framework created to deal with future pandemics.
"This system is intended to ensure that when a country provides its information, the benefits – including vaccines and treatments – are shared equitably, not commercialised exclusively by those with the funds to create them."
Zimbabwe's reservations over the US deal "must not be interpreted as hostility towards the US," Mangwana stressed.
"We welcome continued discussions with our US partners on how future collaboration might be arranged in a manner that honours the sovereignty and interests of both nations."
Medical Community Reaction
A leading public health body stated it understood the government's concerns, but recommended that talks should continue given that much of the country's HIV programmes depended on international support.
"If specific concerns exist, such as those relating to information security or agreement terms, these can often be addressed via detailed discussion and mutually agreed protections," it said.
The halted deal highlights the complex tensions between receiving crucial international aid and protecting a country's data in an increasingly data-driven world.